Tufts Professor Name Editor-In-Chief Of New England Journal Of Medicine

Tufts Professor Named Editor-In-Chief Of New England Journal Of Medicine Author: Rebecca Andrews (The Scientist, Vol:5, #5, pg.21, March 4, 1991) (Copyright, The Scientist, Inc.) ---------- Jerome P. Kassirer, associate physician-in-chief at the New England Medicine Center in Boston and Sara Murray Jordan Professor of Medicine at Tufts University School of Medicine, Boston, has been named editor-in-chief of the New England Journal of Medicine (NEJM), effective July 1991. Kassir

Written byRebecca Andrews
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

(The Scientist, Vol:5, #5, pg.21, March 4, 1991) (Copyright, The Scientist, Inc.)

----------

Jerome P. Kassirer, associate physician-in-chief at the New England Medicine Center in Boston and Sara Murray Jordan Professor of Medicine at Tufts University School of Medicine, Boston, has been named editor-in-chief of the New England Journal of Medicine (NEJM), effective July 1991. Kassirer will succeed Arnold Relman, who announced his plans to retire last July after 14 years as the journal's top editor.

Kassirer, a nephrologist and internal medicine specialist with extensive experience in writing and editing, says that under his direction, the journal will evolve. However, at present he is reluctant to predict the types of changes he will institute. "The same principle that holds to taking care of the sick holds to taking care of a prestigious medical journal," says Kassirer. "Primum non nocere--first do no harm."

Kassirer is well known for his research into ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies